Literature DB >> 25601015

Gender differences in patients with first-episode psychosis in the Singapore Early Psychosis Intervention Programme.

Shirlene Pang1, Mythily Subramaniam2, Edimansyah Abdin2, Lye Yin Poon3, Siow Ann Chong2, Swapna Verma3.   

Abstract

AIMS: This study aimed to identify the gender differences among multi-ethnic, Asian patients with first-episode psychosis attending the Early Psychosis Intervention Programme (EPIP) in Singapore.
METHODS: Data for this study were derived from 533 (258 female, 275 male) patients aged 16-41 years old in the EPIP database. Socio-demographic data, Positive and Negative Syndrome Scale for schizophrenia (PANSS) and Global Assessment of Functioning (GAF) scores at baseline, 3 months, 6 months and 1 year were obtained.
RESULTS: Significant gender differences were identified in terms of age, marital status, referral source, PANSS scores, GAF scores, remission and recovery over 1 year in the cohort. At service entry, female participants were older, more likely to be married and more likely to be referred from general practitioner/polyclinics (P < 0.0001). They showed better improvement over 1 year in PANSS positive, PANSS total, GAF disability and GAF total scores.
CONCLUSIONS: Overall, female participants in this sample show better improvement than male participants. They showed a better course of illness over 1 year with one-third (33.3%) of female participants achieving recovery compared with approximately a quarter (23.6%) of male participants.
© 2015 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  early intervention; early psychosis; first-episode psychosis; gender difference; remission

Mesh:

Year:  2015        PMID: 25601015     DOI: 10.1111/eip.12208

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  7 in total

1.  Time trends in first admission rates for schizophrenia and other psychotic disorders in Taiwan, 1998-2007: a 10-year population-based cohort study.

Authors:  Chih-Lin Chiang; Pei-Chun Chen; Ling-Ya Huang; Po-Hsiu Kuo; Yu-Chi Tung; Chen-Chung Liu; Wei J Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-12-27       Impact factor: 4.328

2.  Sex Differences in Clinical and Functional Outcomes among Patients Treated in an Early Intervention Service for Psychotic Disorders: An Observational Study.

Authors:  Manish Dama; Franz Veru; Norbert Schmitz; Jai Shah; Srividya Iyer; Ridha Joober; Ashok Malla
Journal:  Can J Psychiatry       Date:  2019-06-12       Impact factor: 4.356

3.  Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences.

Authors:  Esther Setién-Suero; Karl Neergaard; Mariluz Ramírez-Bonilla; Patricia Correa-Ghisays; Lourdes Fañanás; Benedicto Crespo-Facorro; Rosa Ayesa-Arriola
Journal:  PLoS One       Date:  2017-08-23       Impact factor: 3.240

4.  Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.

Authors:  Edimansyah Abdin; Siow Ann Chong; Janhavi Ajit Vaingankar; Chao Xu Peh; Lye Yin Poon; Sujatha Rao; Swapna Verma; Mythily Subramaniam
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 5.  First-episode psychosis: How long does it last? A review of evolution and trajectory.

Authors:  Jyoti Prakash; K Chatterjee; K Srivastava; V S Chauhan
Journal:  Ind Psychiatry J       Date:  2021-07-20

6.  Family History of Psychiatric Disorders and Clinical Factors Associated With a Schizophrenia Diagnosis.

Authors:  Lina Díaz-Castro; Kurt Hoffman; Héctor Cabello-Rangel; Armando Arredondo; Miguel Ángel Herrera-Estrella
Journal:  Inquiry       Date:  2021 Jan-Dec       Impact factor: 1.730

7.  Subjective Quality of Life and Its Associations among First Episode Psychosis Patients in Singapore.

Authors:  Pratika Satghare; Edimansyah Abdin; Shazana Shahwan; Boon Yiang Chua; Lye Yin Poon; Siow Ann Chong; Mythily Subramaniam
Journal:  Int J Environ Res Public Health       Date:  2019-12-30       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.